Consolidated Statements of Cash Flows (Unaudited) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,650,557)	$ (3,536,076)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Common stock issued for the extension of patent and license agreement	300,000
Amortization of intangibles	54,308
Gain on issuance of Forte license agreement		(3,165,151)
Loss on impairment on investment in common stock		2,645,000
Loss (gain) on settlement of obligations		1,166,418
Loss from warrant modification		1,605,913
Changes in operating assets and liabilities:
Deposits	45,228	(50,728)
Accounts payable	50,618	388,539
License fees payable	(253,849)
Accrued payroll		4,620
Accrued interest	87,860	130,229
Accrued liabilities		(75,321)
Due to related parties	709,858	304,736
Net cash used in operating activities	(656,534)	(581,821)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of intangible assets		(500,000)
Net cash used in investing activities		(500,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from undocumented investor advances		6,369
Proceeds from related parties	100,000	417,058
Proceeds from issuance of notes payable	435,828	315,000
Net cash provided by financing activities	535,828	738,427
(Decrease) increase in cash	(120,705)	(343,394)
Cash and cash equivalents, beginning of year	150,491	493,885
Cash and cash equivalents, end of year	29,786	150,491
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Reclassification of accrued interest to notes payable		7,006,492
Conversion of notes and accrued interest to common stock	42,703	95,973
Stock issued for intangible assets		$ 262,500